| 000 | 01718 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513221634.0 | ||
| 264 | 0 | _c20001103 | |
| 008 | 200011s 0 0 eng d | ||
| 022 | _a0027-8424 | ||
| 024 | 7 |
_a10.1073/pnas.97.20.10917 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGnjatic, S | |
| 245 | 0 | 0 |
_aStrategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cSep 2000 |
||
| 300 |
_a10917-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 | _aAntigen Presentation |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aCytotoxicity, Immunologic |
| 650 | 0 | 4 | _aGene Transfer Techniques |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 |
_aHistocompatibility Antigens Class I _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMembrane Proteins |
| 650 | 0 | 4 |
_aProteins _xgenetics |
| 650 | 0 | 4 | _aVaccinia virus |
| 700 | 1 | _aNagata, Y | |
| 700 | 1 | _aJager, E | |
| 700 | 1 | _aStockert, E | |
| 700 | 1 | _aShankara, S | |
| 700 | 1 | _aRoberts, B L | |
| 700 | 1 | _aMazzara, G P | |
| 700 | 1 | _aLee, S Y | |
| 700 | 1 | _aDunbar, P R | |
| 700 | 1 | _aDupont, B | |
| 700 | 1 | _aCerundolo, V | |
| 700 | 1 | _aRitter, G | |
| 700 | 1 | _aChen, Y T | |
| 700 | 1 | _aKnuth, A | |
| 700 | 1 | _aOld, L J | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 97 _gno. 20 _gp. 10917-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.97.20.10917 _zAvailable from publisher's website |
| 999 |
_c10951796 _d10951796 |
||